Papers

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

^a Projekt "Munchener Modell," Ludwig-Maximilians-Universitat, Kaiserstrasse 9, 80801 Munich, Germany, ^b San Antonio Cochrane Center, Audie L Murphy Memorial Veterans Hospital, San Antonio, TX 78284, USA, ^c Private Practice for Neurology and Psychiatry, 80796 Munich

Correspondence to: Dr Linde.

Abstract

Objective: To investigate if extracts of Hypericum perforatum (St John's wort) are more effective than placebo in the treatment of depression, are as effective as standard antidepressive treatment, and have fewer side effects than standard antidepressant drugs.
Design: Systematic review and meta-analysis of trials revealed by searches.
Trials: 23 randomised trials including a total of 1757 outpatients with mainly mild or moderately severe depressive disorders: 15 (14 testing single preparations and one a combination with other plant extracts) were placebo controlled, and eight (six testing single preparations and two combinations) compared hypericum with another drug treatment.
Main outcome measures: A pooled estimate of the responder rate ratio (responder rate in treatment group/responder rate in control group), and numbers of patients reporting and dropping out for side effects.
Results: Hypericum extracts were significantly superior to placebo (ratio = 2.67; 95% confidence interval 1.78 to 4.01) and similarly effective as standard antidepressants (single preparations 1.10; 0.93 to 1.31, combinations 1.52; 0.78 to 2.94). There were two (0.8%) drop outs for side effects with hypericum and seven (3.0%) with standard antidepressant drugs. Side effects occurred in 50 (19.8%) patients on hypericum and 84 (52.8%) patients on standard antidepressants.
Conclusion: There is evidence that extracts of hypericum are more effective than placebo for the treatment of mild to moderately severe depressive disorders. Further studies comparing extracts with standard antidepressants in well defined groups of patients and comparing different extracts and doses are needed.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Use of hypericum as antidepressant

Andrew Thornett, Mike Walton, Andrew Vickers, Tim Gorski, David B Menkes, Peter Balfour, Michael Philipp, Ralf Kohnen, and Karl-O Hiller
BMJ 2000 320: 1141. [Extract] [Full Text]

St John's wort for depression

Peter J Houghton
BMJ 1996 313: 1204-1205. [Extract] [Full Text]

This article has been cited by other articles:

• Whelan, A. M., Jurgens, T. M., Lord, L. (2009). Evaluating the Quality of Randomized Controlled Trials that Examine the Efficacy of Natural Health Products: A Systematic Review of Critical Appraisal Instruments. Evid Based Complement Alternat Med 6: 441-448 [Abstract] [Full text]  
• Mullin, G. E. (2009). Issues in Complementary and Alternative Nutrition Treatments. Nutr Clin Pract 24: 543-548 [Full text]  
• Dunne, F. J. (2009). The 'Natural Health Service': natural does not mean safe. Adv. Psychiatr. Treat. 15: 49-56 [Abstract] [Full text]  
• Viana, A., Rates, S., Naudin, B., Janin, F., Costentin, J., do Rego, J-C. (2008). Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels. J Psychopharmacol 22: 681-690 [Abstract]  
• Tyrer, P. (2008). From the Editor's desk. Br. J. Psychiatry 193: 90-90 [Full text]  
• Wahlberg, A. (2008). Above and beyond superstition -- western herbal medicine and the decriminalizing of placebo. History of the Human Sciences 21: 77-101 [Abstract]  
• Uzbay, I. T. (2008). Serotonergic anti-depressants and ethanol withdrawal syndrome: A review. Alcohol Alcohol 43: 15-24 [Abstract] [Full text]  
• Calapai, G., Caputi, A. P. (2007). Herbal Medicines: Can We Do Without Pharmacologist?. Evid Based Complement Alternat Med 4: 41-43 [Abstract] [Full text]  
• Reed, J. E., Trigwell, P. (2006). Treatments recommended by health shops for symptoms of depression. Psychiatr. Bull. 30: 365-368 [Abstract] [Full text]  
• WERNEKE, U., TURNER, T., PRIEBE, S. (2006). Complementary medicines in psychiatry: Review of effectiveness and safety. Br. J. Psychiatry 188: 109-121 [Abstract] [Full text]  
• Komoroski, B. J., Parise, R. A., Egorin, M. J., Strom, S. C., Venkataramanan, R. (2005). Effect of the St. John's Wort Constituent Hyperforin on Docetaxel Metabolism by Human Hepatocyte Cultures. Clin. Cancer Res. 11: 6972-6979 [Abstract] [Full text]  
• Shekelle, P. G., Morton, S. C., Suttorp, M. J., Buscemi, N., Friesen, C. (2005). Challenges in Systematic Reviews of Complementary and Alternative Medicine Topics. ANN INTERN MED 142: 1042-1047 [Abstract] [Full text]  
• Lett, H. S., Davidson, J., Blumenthal, J. A. (2005). Nonpharmacologic Treatments for Depression in Patients With Coronary Heart Disease. Psychosom. Med. 67: S58-S62 [Abstract] [Full text]  
• Tian, R., Koyabu, N., Morimoto, S., Shoyama, Y., Ohtani, H., Sawada, Y. (2005). FUNCTIONAL INDUCTION AND DE-INDUCTION OF P-GLYCOPROTEIN BY ST. JOHN'S WORT AND ITS INGREDIENTS IN A HUMAN COLON ADENOCARCINOMA CELL LINE. Drug Metab. Dispos. 33: 547-554 [Abstract] [Full text]  
• LINDE, K., BERNER, M., EGGER, M., MULROW, C. (2005). St John's wort for depression: Meta-analysis of randomised controlled trials. Br. J. Psychiatry 186: 99-107 [Abstract] [Full text]  
• Appelhof, B. C., Brouwer, J. P., van Dyck, R., Fliers, E., Hoogendijk, W. J. G., Huyser, J., Schene, A. H., Tijssen, J. G. P., Wiersinga, W. M. (2004). Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive Disorder. J. Clin. Endocrinol. Metab. 89: 6271-6276 [Abstract] [Full text]  
• Krochmal, R., Hardy, M., Bowerman, S., Lu, Q.-Y., Wang, H-J, Elashoff, R., Heber, D. (2004). Phytochemical Assays of Commercial Botanical Dietary Supplements. Evid Based Complement Alternat Med 1: 305-313 [Abstract] [Full text]  
• Sparreboom, A., Cox, M. C., Acharya, M. R., Figg, W. D. (2004). Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents. JCO 22: 2489-2503 [Abstract] [Full text]  
• Komoroski, B. J., Zhang, S., Cai, H., Hutzler, J. M., Frye, R., Tracy, T. S., Strom, S. C., Lehmann, T., Ang, C. Y. W., Cui, Y. Y., Venkataramanan, R. (2004). INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES. Drug Metab. Dispos. 32: 512-518 [Abstract] [Full text]  
• Costa, L. G., Steardo, L., Cuomo, V. (2004). Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects. Pharmacol. Rev. 56: 103-147 [Abstract] [Full text]  
• Zellweger, M. J., Osterwalder, R. H., Langewitz, W., Pfisterer, M. E. (2004). Coronary artery disease and depression. Eur Heart J 25: 3-9 [Abstract] [Full text]  
• Wright, C. W., Gott, M., Grayson, B., Smith, A. G., Sunter, A., Neill, J. C., Hanna, M. (2003). Correlation of Hyperforin Content of Hypericum Perforatum(St John's Wort) Extracts with Their Effects On Alcohol Drinking in C57Bl/6J Mice: A Preliminary Study. J Psychopharmacol 17: 403-408 [Abstract]  
• Ernst, E (2003). Herbal medicines put into context. BMJ 327: 881-882 [Full text]  
• Morris, C. A., Avorn, J. (2003). Internet Marketing of Herbal Products. JAMA 290: 1505-1509 [Abstract] [Full text]  
• Cantoni, L., Rozio, M., Mangolini, A., Hauri, L., Caccia, S. (2003). Hyperforin Contributes to the Hepatic CYP3A-Inducing Effect of Hypericum perforatum Extract in the Mouse. Toxicol Sci 75: 25-30 [Abstract] [Full text]  
• Bais, H. P., Vepachedu, R., Lawrence, C. B., Stermitz, F. R., Vivanco, J. M. (2003). Molecular and Biochemical Characterization of an Enzyme Responsible for the Formation of Hypericin in St. John's Wort (Hypericum perforatum L.). J. Biol. Chem. 278: 32413-32422 [Abstract] [Full text]  
• Hammerness, P., Basch, E., Ulbricht, C., Barrette, E.-P., Foppa, I., Basch, S., Bent, S., Boon, H., Ernst, E. (2003). St. John's Wort: A Systematic Review of Adverse Effects and Drug Interactions for the Consultation Psychiatrist. Psychosomatics 44: 271-282 [Abstract] [Full text]  
• Woolf, A. D. (2003). Herbal Remedies and Children: Do They Work? Are They Harmful?. Pediatrics 112: 240-246 [Abstract] [Full text]  
• Zuess, J. (2003). An Integrative Approach to Depression: Part 2--Assessment and Treatment. Complementary Health Practice Review 8: 99-115 [Abstract]  
• Dean, A. J, Moses, G. M, Vernon, J. M (2003). Suspected withdrawal syndrome after cessation of St. John's wort. The Annals of Pharmacotherapy 37: 150-150 [Full text]  
• Remick, R. A. (2002). Diagnosis and management of depression in primary care: a clinical update and review. CMAJ 167: 1253-1260 [Abstract] [Full text]  
• Perfumi, M., Santoni, M., Ciccocioppo, R., Massi, M. (2002). BLOCKADE OF {gamma}-AMINOBUTYRIC ACID RECEPTORS DOES NOT MODIFY THE INHIBITION OF ETHANOL INTAKE INDUCED BY HYPERICUM PERFORATUM IN RATS. Alcohol Alcohol 37: 540-546 [Abstract] [Full text]  
• Lecrubier, Y., Clerc, G., Didi, R., Kieser, M. (2002). Efficacy of St. John's Wort Extract WS 5570 in Major Depression: A Double-Blind, Placebo-Controlled Trial. Am. J. Psychiatry 159: 1361-1366 [Abstract] [Full text]  
• Jonas, W., Wheatley, D., Spielmans, G. I., Volp, A., Linde, K., Melchart, D., Mulrow, C. D., Berner, M., Cott, J., Wisner, K. L., Davidson, J. R. T., Kupfer, D. J., Frank, E. (2002). St John's Wort and Depression. JAMA 288: 446-449 [Full text]  
• Buchholzer, M.-L., Dvorak, C., Chatterjee, S. S., Klein, J. (2002). Dual Modulation of Striatal Acetylcholine Release by Hyperforin, a Constituent of St. John's Wort. J. Pharmacol. Exp. Ther. 301: 714-719 [Abstract] [Full text]  
• Cohen, M. H., Eisenberg, D. M. (2002). Potential Physician Malpractice Liability Associated with Complementary and Integrative Medical Therapies. ANN INTERN MED 136: 596-603 [Abstract] [Full text]  
• Hypericum Depression Trial Study Group, (2002). Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder: A Randomized Controlled Trial. JAMA 287: 1807-1814 [Abstract] [Full text]  
• Kupfer, D. J., Frank, E. (2002). Placebo in Clinical Trials for Depression: Complexity and Necessity. JAMA 287: 1853-1854 [Full text]  
• Hawley, C., Dale, T. (2002). St John's wort was not better than placebo for reducing depression scores. Evid. Based Ment. Health 5: 24-24 [Full text]  
• Emanuel, A. M., Moore, T. R., Ghazvini, P. (2001). Considerations for the Use of Alternative Therapies in the Treatment of Depression. Journal of Pharmacy Practice 14: 551-559 [Abstract]  
• Hawley, C., Gale, T. (2001). St John's wort was no better than placebo for reducing depression scores. Evid. Based Med. 6: 185-185 [Full text]  
• Penson, R. T., Castro, C. M., Seiden, M. V., Chabner, B. A., Lynch, T. J. Jr. (2001). Complementary, Alternative, Integrative, or Unconventional Medicine?. The Oncologist 6: 463-473 [Abstract] [Full text]  
• Cott, J. M., Rosenthal, N., Blumenthal, M., Fomous, C. M., Cardellina II, J. H., Cohen, H. W., Marantz, P. R., Brenner, R., Madhusoodanan, S., Pawlowska, M., Czobor, P., Fugh-Berman, A., Shelton, R. C., Crits-Christoph, P. (2001). St John's Wort and Major Depression. JAMA 286: 42-45 [Full text]  
• (2001). The Use of Herbal and Botanical Therapies in Menopause. JWatch Women's Health 2001: 11-11 [Full text]  
• Redvers, A., Laugharne, R., Kanagaratnam, G., Srinivasan, G. (2001). How many patients self-medicate with St John's wort?. Psychiatr. Bull. 25: 254-256 [Abstract] [Full text]  
• Perfumi, M., Panocka, I., Ciccocioppo, R., Vitali, D., Froldi, R., Massi, M. (2001). Effects of a methanolic extract and a hyperforin-enriched CO2 extract of Hypericum perforatum on alcohol intake in rats. Alcohol Alcohol 36: 199-206 [Abstract] [Full text]  
• Hotopf, M. (2001). Hypericum extract was as effective as imipramine but had fewer adverse effects in mild to moderate depressionCommentary. Evid. Based Ment. Health 4: 56-56 [Full text]  
• Shelton, R. C., Keller, M. B., Gelenberg, A., Dunner, D. L., Hirschfeld, R., Thase, M. E., Russell, J., Lydiard, R. B., Crits-Christoph, P., Gallop, R., Todd, L., Hellerstein, D., Goodnick, P., Keitner, G., Stahl, S. M., Halbreich, U. (2001). Effectiveness of St John's Wort in Major Depression: A Randomized Controlled Trial. JAMA 285: 1978-1986 [Abstract] [Full text]  
• Schempp, C. M., Muller, K., Winghofer, B., Schulte-Monting, J., Simon, J. C. (2001). Single-Dose and Steady-State Administration of Hypericum perforatum Extract (St John's Wort) Does Not Influence Skin Sensitivity to UV Radiation, Visible Light, and Solar-Simulated Radiation. Arch Dermatol 137: 512-513 [Full text]  
• Massion, C. T. (2001). 20 Common Problems in Women's Health Care. JAMA 285: 1513-1515 [Full text]  
• Cornwall, P. L, Spira, J. L, Alkhenizan, A., Völp, A., Woelk, H (2001). Comparison of St John's wort and imipramine. BMJ 322: 493-493 [Full text]  
• Liepa, G. (2001). Editorial: Cardioprotective Effects of {omega}-3 Fatty Acids: A Critical Review That Should Be Read by a Wide Range of Health Professionals. Nutr Clin Pract 16: 5-5  
• Kessler, R. C., Soukup, J., Davis, R. B., Foster, D. F., Wilkey, S. A., Van Rompay, M. I., Eisenberg, D. M. (2001). The Use of Complementary and Alternative Therapies to Treat Anxiety and Depression in the United States. Am. J. Psychiatry 158: 289-294 [Abstract] [Full text]  
• Sardesai, V. M., Myers, T. (2001). Clinincal Observations: Nutrient Supplements in Clinical Care. Nutr Clin Pract 16: 35-45 [Abstract]  
• Nahin, R. L, Straus, S. E (2001). Research into complementary and alternative medicine: problems and potential. BMJ 322: 161-164 [Full text]  
• Nathan, P. J. (2001). Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology. J Psychopharmacol 15: 47-54 [Abstract]  
• Whooley, M. A., Simon, G. E. (2000). Managing Depression in Medical Outpatients. NEJM 343: 1942-1950 [Full text]  
• Unützer, J., Klap, R., Sturm, R., Young, A. S., Marmon, T., Shatkin, J., Wells, K. B. (2000). Mental Disorders and the Use of Alternative Medicine: Results From a National Survey. Am. J. Psychiatry 157: 1851-1857 [Abstract] [Full text]  
• JORM, A. F. (2000). Mental health literacy: Public knowledge and beliefs about mental disorders. Br. J. Psychiatry 177: 396-401 [Abstract] [Full text]  
• Woelk, H. (2000). Comparison of St John's wort and imipramine for treating depression: randomised controlled trial. BMJ 321: 536-539 [Abstract] [Full text]  
• Beaubrun, G., Gray, G. E. (2000). A Review of Herbal Medicines for Psychiatric Disorders. Psychiatr. Serv. 51: 1130-1134 [Abstract] [Full text]  
• Ernst, E (2000). Herbal medicines: where is the evidence?. BMJ 321: 395-396 [Full text]  
• Franklin, M., Chi, J. D., Mannel, M., Cowen, P. J. (2000). Acute effects of LI 160 (extract of Hypericum perforatum, St John's wort) and two of its constituents on neuroendocrine responses in the rat. J Psychopharmacol 14: 360-363 [Abstract]  
• Druss, B. G., Rosenheck, R. A. (2000). Use of Practitioner-Based Complementary Therapies by Persons Reporting Mental Conditions in the United States. Arch Gen Psychiatry 57: 708-714 [Abstract] [Full text]  
• Zahourek, R. (2000). Alternative, Complementary, or Integrative Approaches to Treating Depression. J Am Psychiatr Nurses Assoc 6: 77-86 [Abstract]  
• Maidment, I. (2000). The use of St John's Wort in the treatment of depression. Psychiatr. Bull. 24: 232-234 [Abstract] [Full text]  
• Williams, J. W. Jr., Mulrow, C. D., Chiquette, E., Noel, P. H., Aguilar, C., Cornell, J. (2000). A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2. ANN INTERN MED 132: 743-756 [Abstract] [Full text]  
• LaFrance, W. C. Jr., Lauterbach, E. C., Coffey, C. E., Salloway, S. P., Kaufer, D. I., Reeve, A., Royall, D. R., Aylward, E., Rummans, T. A., Lovell, M. R. (2000). The Use of Herbal Alternative Medicines in Neuropsychiatry: A Report of the ANPA Committee on Research. J. Neuropsychiatry Clin. Neurosi. 12: 177-192 [Abstract] [Full text]  
• Thornett, A., Walton, M., Vickers, A., Gorski, T., Menkes, D. B, Balfour, P., Philipp, M., Kohnen, R., Hiller, K.-O (2000). Use of hypericum as antidepressant. BMJ 320: 1141a-1141 [Full text]  
• Gardiner, P., Kemper, K. J. (2000). Herbs in Pediatric and Adolescent Medicine. Pediatr. Rev. 21: 44-57 [Full text]  
• Gaster, B., Holroyd, J. (2000). St John's Wort for Depression: A Systematic Review. Arch Intern Med 160: 152-156 [Abstract] [Full text]  
• Barbenel, D. M., Yusufi, B., O'Shea, D., Bench, C. J. (2000). Mania in a patient receiving testosterone replacement post-orchidectomy taking St John's wort and sertraline. J Psychopharmacol 14: 84-86 [Abstract]  
• McEnany, G. (1999). Herbal Psychotropics. Part 1: Focus on St. John's Wort and SAMe. J Am Psychiatr Nurses Assoc 5: 192-196  
• Vickers, A. (1999). Evidence-based medicine and complementary medicine. Evid. Based Ment. Health 2: 102-103 [Full text]  
• Yager, J., Siegfreid, S. L., DiMatteo, T. L. (1999). Use of Alternative Remedies by Psychiatric Patients: Illustrative Vignettes and a Discussion of the Issues. Am. J. Psychiatry 156: 1432-1438 [Full text]  
• Perfumi, M., Ciccocioppo, R., Angeletti, S., Cucculelli, M., Massi, M. (1999). EFFECTS OF HYPERICUM PERFORATUM EXTRACT ON ALCOHOL INTAKE IN MARCHIGIAN SARDINIAN ALCOHOL-PREFERRING RATS. Alcohol Alcohol 34: 690-698 [Abstract] [Full text]  
• Singer, A., Wonnemann, M., Müller, W. E. (1999). Hyperforin, a Major Antidepressant Constituent of St. John's Wort, Inhibits Serotonin Uptake by Elevating Free Intracellular Na+1 1. J. Pharmacol. Exp. Ther. 290: 1363-1368 [Abstract] [Full text]  
• Fugh-Berman, A., Cott, J. M. (1999). Dietary Supplements and Natural Products as Psychotherapeutic Agents. Psychosom. Med. 61: 712-728 [Abstract] [Full text]  
• Khawaja, I. S., Marotta, R. F., Lippmann, S. (1999). Herbal Medicines as a Factor in Delirium. Psychiatr. Serv. 50: 969a-970a [Full text]  
• Kopec, K. (1999). Herbal Medications and Breastfeeding. J Hum Lact 15: 157-161  
• Lantz, M. S., Buchalter, E., Giambanco, V. (1999). St. John's Wort and Antidepressant Drug Interactions in the Elderly. J Geriatr Psychiatry Neurol 12: 7-10 [Abstract]  
• Gulick, R. M., McAuliffe, V., Holden-Wiltse, J., Crumpacker, C., Liebes, L., Stein, D. S., Meehan, P., Hussey, S., Forcht, J., Valentine, F. T., for the AIDS Clinical Trials Group 150 and 258 Pro, (1999). Phase I Studies of Hypericin, the Active Compound in St. John's Wort, as an Antiretroviral Agent in HIV-Infected Adults: AIDS Clinical Trials Group Protocols 150 and 258. ANN INTERN MED 130: 510-514 [Abstract] [Full text]  
• Anderson, D. A., Wadden, T. A. (1999). Treating the Obese Patient: Suggestions for Primary Care Practice. Arch Fam Med 8: 156-167 [Abstract] [Full text]  
• Turow, V. (1998). Herbal Therapy for Children. Pediatrics 102: 1492-1492 [Full text]  
• Ezzo, J., Berman, B. M., Vickers, A. J., Linde, K. (1998). Complementary Medicine and the Cochrane Collaboration. JAMA 280: 1628-1630 [Full text]  
• Winslow, L. C., Kroll, D. J. (1998). Herbs as Medicines. Arch Intern Med 158: 2192-2199 [Abstract] [Full text]  
• Miller, L. G. (1998). Herbal Medicinals: Selected Clinical Considerations Focusing on Known or Potential Drug-Herb Interactions. Arch Intern Med 158: 2200-2211 [Abstract] [Full text]  
• O'Hara, M., Kiefer, D., Farrell, K., Kemper, K. (1998). A Review of 12 Commonly Used Medicinal Herbs. Arch Fam Med 7: 523-536 [Abstract] [Full text]  
• Ernst, E., Rand, J. I., Stevinson, C. (1998). Complementary Therapies for Depression: An Overview. Arch Gen Psychiatry 55: 1026-1032 [Abstract] [Full text]  
• Wong, A. H. C., Smith, M., Boon, H. S. (1998). Herbal Remedies in Psychiatric Practice. Arch Gen Psychiatry 55: 1033-1044 [Abstract] [Full text]  
• Bowman, M. A., Nicklin, D. E. (1998). New Developments in Family Medicine. JAMA 279: 1437-1438 [Full text]  
• Jonas, W. (1998). Alternative Medicine and the Conventional Practitioner. JAMA 279: 708-709 [Full text]  
• Bartels, C. L., Miller, S. J. (1998). Herbal and Related Remedies. Nutr Clin Pract 13: 5-19 [Abstract]  
• Rampes, H. (1997). Hypericum, an over the counter antidepressant?. J Psychopharmacol 11: 191-191  
• Houghton, P. J (1996). St John's wort for depression. BMJ 313: 1204b-1205 [Full text]  
• De Smet, P. A G M, Nolen, W. A (1996). St John's wort as an antidepressant. BMJ 313: 241-242 [Full text]  

Rapid Responses:

Read all Rapid Responses

Clarifications

John Wright
bmj.com, 16 Feb 2000 [Full text]

Herbal drugs versus monoaminergic neurotransmitter reuptake inhibitors

Erdem Tuzun
bmj.com, 1 Sep 2001 [Full text]